Global Swine Vaccines Market By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines) By Type(Porcine Circovirus Type 2, Swine Influenza, Classical Swine Fever, Porcine Parvovirus, M.Hyo, Actinobacillus Pleuropneumonia, PRRS, Foot & Mouth Disease, Pseudorabies, Others) By Distribution Channel (Veterinary Hospitals& Clinics, Veterinary Research Instritutes, Laboratories, Others) By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: March 2024
- Report ID: 34933
- Number of Pages: 391
- Format:
- keyboard_arrow_up
- 1. Executive Summary
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 1.4. Key Analysis
- 1.5. Key Findings by Major Segments
- 1.6. Top strategies by Major Players
- 2. Global Swine Vaccines Overview
- 2.1. Swine Vaccines Dynamics
- 2.1.1. Drivers
- 2.1.2. Opportunities
- 2.1.3. Restraints
- 2.1.4. Challenges
- 2.2. Macro-economic Factors
- 2.3. Regulatory Framework
- 2.4. Market Investment Feasibility Index
- 2.5. PEST Analysis
- 2.6. PORTER’S Five Force Analysis
- 2.7. Drivers & Restraints Impact Analysis
- 2.8. Industry Chain Analysis
- 2.9. Cost Structure Analysis
- 2.10. Marketing Strategy
- 2.11. Russia-Ukraine War Impact Analysis
- 2.12. Opportunity Map Analysis
- 2.13. Market Competition Scenario Analysis
- 2.14. Product Life Cycle Analysis
- 2.15. Opportunity Orbits
- 2.16. Manufacturer Intensity Map
- 2.17. Major Companies sales by Value & Volume
- 2.1. Swine Vaccines Dynamics
- 3. Global Swine Vaccines Analysis, Opportunity and Forecast, 2016-2032
- 3.1. Global Swine Vaccines Analysis, 2016-2021
- 3.2. Global Swine Vaccines Opportunity and Forecast, 2023-2032
- 3.3. Global Swine Vaccines Analysis, Opportunity and Forecast, By Product, 2016-2032
- 3.3.1. Global Swine Vaccines Analysis by Product: Introduction
- 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
- 3.3.3. Inactivated Vaccines
- 3.3.4. Attenuated Live Vaccines
- 3.3.5. DNA Vaccines
- 3.3.6. Subunit Vaccines
- 3.3.7. Recombinant Vaccines
- 3.4. Global Swine Vaccines Analysis, Opportunity and Forecast, By Type, 2016-2032
- 3.4.1. Global Swine Vaccines Analysis by Type: Introduction
- 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 3.4.3. Swine Influenza
- 3.4.4. Porcine Parvovirus
- 3.4.5. Classical Swine Fever
- 3.4.6. M.Hyo
- 3.4.7. Porcine Circovirus Type 2
- 3.4.8. PRRS
- 3.4.9. ActinobacillusPleuropneumonia
- 3.4.10. Pseudorabies
- 3.4.11. Foot & Mouth Disease
- 3.4.12. PEDV
- 3.4.13. Others
- 4. North America Swine Vaccines Analysis, Opportunity and Forecast, 2016-2032
- 4.1. North America Swine Vaccines Analysis, 2016-2021
- 4.2. North America Swine Vaccines Opportunity and Forecast, 2023-2032
- 4.3. North America Swine Vaccines Analysis, Opportunity and Forecast, By Product, 2016-2032
- 4.3.1. North America Swine Vaccines Analysis by Product: Introduction
- 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
- 4.3.3. Inactivated Vaccines
- 4.3.4. Attenuated Live Vaccines
- 4.3.5. DNA Vaccines
- 4.3.6. Subunit Vaccines
- 4.3.7. Recombinant Vaccines
- 4.4. North America Swine Vaccines Analysis, Opportunity and Forecast, By Type, 2016-2032
- 4.4.1. North America Swine Vaccines Analysis by Type: Introduction
- 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 4.4.3. Swine Influenza
- 4.4.4. Porcine Parvovirus
- 4.4.5. Classical Swine Fever
- 4.4.6. M.Hyo
- 4.4.7. Porcine Circovirus Type 2
- 4.4.8. PRRS
- 4.4.9. ActinobacillusPleuropneumonia
- 4.4.10. Pseudorabies
- 4.4.11. Foot & Mouth Disease
- 4.4.12. PEDV
- 4.4.13. Others
- 4.5. North America Swine Vaccines Analysis, Opportunity and Forecast, By Country , 2016-2032
- 4.5.1. North America Swine Vaccines Analysis by Country : Introduction
- 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 4.5.2.1. U.S.
- 4.5.2.2. Canada
- 4.5.2.3. Mexico
- 5. Europe Swine Vaccines Analysis, Opportunity and Forecast, 2016-2032
- 5.1. Europe Swine Vaccines Analysis, 2016-2021
- 5.2. Europe Swine Vaccines Opportunity and Forecast, 2023-2032
- 5.3. Europe Swine Vaccines Analysis, Opportunity and Forecast, By Product, 2016-2032
- 5.3.1. Europe Swine Vaccines Analysis by Product: Introduction
- 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
- 5.3.3. Inactivated Vaccines
- 5.3.4. Attenuated Live Vaccines
- 5.3.5. DNA Vaccines
- 5.3.6. Subunit Vaccines
- 5.3.7. Recombinant Vaccines
- 5.4. Europe Swine Vaccines Analysis, Opportunity and Forecast, By Type, 2016-2032
- 5.4.1. Europe Swine Vaccines Analysis by Type: Introduction
- 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 5.4.3. Swine Influenza
- 5.4.4. Porcine Parvovirus
- 5.4.5. Classical Swine Fever
- 5.4.6. M.Hyo
- 5.4.7. Porcine Circovirus Type 2
- 5.4.8. PRRS
- 5.4.9. ActinobacillusPleuropneumonia
- 5.4.10. Pseudorabies
- 5.4.11. Foot & Mouth Disease
- 5.4.12. PEDV
- 5.4.13. Others
- 5.5. Europe Swine Vaccines Analysis, Opportunity and Forecast, By Country , 2016-2032
- 5.5.1. Europe Swine Vaccines Analysis by Country : Introduction
- 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 5.5.2.1. U.K.
- 5.5.2.2. Germany
- 5.5.2.3. France
- 5.5.2.4. Spain
- 5.5.2.5. Italy
- 5.5.2.6. Russia
- 5.5.2.7. Rest of Europe
- 6. Asia-Pacific Swine Vaccines Analysis, Opportunity and Forecast, 2016-2032
- 6.1. Asia-Pacific Swine Vaccines Analysis, 2016-2021
- 6.2. Asia-Pacific Swine Vaccines Opportunity and Forecast, 2023-2032
- 6.3. Asia-Pacific Swine Vaccines Analysis, Opportunity and Forecast, By Product, 2016-2032
- 6.3.1. Asia-Pacific Swine Vaccines Analysis by Product: Introduction
- 6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
- 6.3.3. Inactivated Vaccines
- 6.3.4. Attenuated Live Vaccines
- 6.3.5. DNA Vaccines
- 6.3.6. Subunit Vaccines
- 6.3.7. Recombinant Vaccines
- 6.4. Asia-Pacific Swine Vaccines Analysis, Opportunity and Forecast, By Type, 2016-2032
- 6.4.1. Asia-Pacific Swine Vaccines Analysis by Type: Introduction
- 6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 6.4.3. Swine Influenza
- 6.4.4. Porcine Parvovirus
- 6.4.5. Classical Swine Fever
- 6.4.6. M.Hyo
- 6.4.7. Porcine Circovirus Type 2
- 6.4.8. PRRS
- 6.4.9. ActinobacillusPleuropneumonia
- 6.4.10. Pseudorabies
- 6.4.11. Foot & Mouth Disease
- 6.4.12. PEDV
- 6.4.13. Others
- 6.5. Asia-Pacific Swine Vaccines Analysis, Opportunity and Forecast, By Country , 2016-2032
- 6.5.1. Asia-Pacific Swine Vaccines Analysis by Country : Introduction
- 6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 6.5.2.1. China
- 6.5.2.2. Japan
- 6.5.2.3. South Korea
- 6.5.2.4. India
- 6.5.2.5. Rest of Asia-Pacific
- 7. South America Swine Vaccines Analysis, Opportunity and Forecast, 2016-2032
- 7.1. South America Swine Vaccines Analysis, 2016-2021
- 7.2. South America Swine Vaccines Opportunity and Forecast, 2023-2032
- 7.3. South America Swine Vaccines Analysis, Opportunity and Forecast, By Product, 2016-2032
- 7.3.1. South America Swine Vaccines Analysis by Product: Introduction
- 7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
- 7.3.3. Inactivated Vaccines
- 7.3.4. Attenuated Live Vaccines
- 7.3.5. DNA Vaccines
- 7.3.6. Subunit Vaccines
- 7.3.7. Recombinant Vaccines
- 7.4. South America Swine Vaccines Analysis, Opportunity and Forecast, By Type, 2016-2032
- 7.4.1. South America Swine Vaccines Analysis by Type: Introduction
- 7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 7.4.3. Swine Influenza
- 7.4.4. Porcine Parvovirus
- 7.4.5. Classical Swine Fever
- 7.4.6. M.Hyo
- 7.4.7. Porcine Circovirus Type 2
- 7.4.8. PRRS
- 7.4.9. ActinobacillusPleuropneumonia
- 7.4.10. Pseudorabies
- 7.4.11. Foot & Mouth Disease
- 7.4.12. PEDV
- 7.4.13. Others
- 7.5. South America Swine Vaccines Analysis, Opportunity and Forecast, By Country , 2016-2032
- 7.5.1. South America Swine Vaccines Analysis by Country : Introduction
- 7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 7.5.2.1. Brazil
- 7.5.2.2. Argentina
- 7.5.2.3. Rest of South America
- 8. Middle East and Africa Swine Vaccines Analysis, Opportunity and Forecast, 2016-2032
- 8.1. Middle East and Africa Swine Vaccines Analysis, 2016-2021
- 8.2. Middle East and Africa Swine Vaccines Opportunity and Forecast, 2023-2032
- 8.3. Middle East and Africa Swine Vaccines Analysis, Opportunity and Forecast, By Product, 2016-2032
- 8.3.1. Middle East and Africa Swine Vaccines Analysis by Product: Introduction
- 8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
- 8.3.3. Inactivated Vaccines
- 8.3.4. Attenuated Live Vaccines
- 8.3.5. DNA Vaccines
- 8.3.6. Subunit Vaccines
- 8.3.7. Recombinant Vaccines
- 8.4. Middle East and Africa Swine Vaccines Analysis, Opportunity and Forecast, By Type, 2016-2032
- 8.4.1. Middle East and Africa Swine Vaccines Analysis by Type: Introduction
- 8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 8.4.3. Swine Influenza
- 8.4.4. Porcine Parvovirus
- 8.4.5. Classical Swine Fever
- 8.4.6. M.Hyo
- 8.4.7. Porcine Circovirus Type 2
- 8.4.8. PRRS
- 8.4.9. ActinobacillusPleuropneumonia
- 8.4.10. Pseudorabies
- 8.4.11. Foot & Mouth Disease
- 8.4.12. PEDV
- 8.4.13. Others
- 8.5. Middle East and Africa Swine Vaccines Analysis, Opportunity and Forecast, By Country , 2016-2032
- 8.5.1. Middle East and Africa Swine Vaccines Analysis by Country : Introduction
- 8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 8.5.2.1. GCC
- 8.5.2.2. Israel
- 8.5.2.3. South Africa
- 8.5.2.4. Rest of MEA
- 9. Global Swine Vaccines Analysis, Opportunity and Forecast, By Region , 2016-2032
- 9.1. Global Swine Vaccines Analysis by Region : Introduction
- 9.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia-Pacific
- 9.2.4. South America
- 9.2.5. Middle East and Africa
- 10. Global Swine Vaccines Competitive Landscape, Market Share Analysis, and Company Profiles
- 10.1. Market Share Analysis
- 10.2. Company Profiles
- 10.3. Merck Animal Health
- 10.3.1. Company Overview
- 10.3.2. Financial Highlights
- 10.3.3. Product Portfolio
- 10.3.4. SWOT Analysis
- 10.3.5. Key Strategies and Developments
- 10.4. Zoetis
- 10.4.1. Company Overview
- 10.4.2. Financial Highlights
- 10.4.3. Product Portfolio
- 10.4.4. SWOT Analysis
- 10.4.5. Key Strategies and Developments
- 10.5. Ceva
- 10.5.1. Company Overview
- 10.5.2. Financial Highlights
- 10.5.3. Product Portfolio
- 10.5.4. SWOT Analysis
- 10.5.5. Key Strategies and Developments
- 10.6. Elanco
- 10.6.1. Company Overview
- 10.6.2. Financial Highlights
- 10.6.3. Product Portfolio
- 10.6.4. SWOT Analysis
- 10.6.5. Key Strategies and Developments
- 10.7. Boehringer Ingelheim GmbH
- 10.7.1. Company Overview
- 10.7.2. Financial Highlights
- 10.7.3. Product Portfolio
- 10.7.4. SWOT Analysis
- 10.7.5. Key Strategies and Developments
- 10.8. BiogenesisBago
- 10.8.1. Company Overview
- 10.8.2. Financial Highlights
- 10.8.3. Product Portfolio
- 10.8.4. SWOT Analysis
- 10.8.5. Key Strategies and Developments
- 10.9. Indian Immunologicals Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Highlights
- 10.9.3. Product Portfolio
- 10.9.4. SWOT Analysis
- 10.9.5. Key Strategies and Developments
- 10.10. KM Biologics
- 10.10.1. Company Overview
- 10.10.2. Financial Highlights
- 10.10.3. Product Portfolio
- 10.10.4. SWOT Analysis
- 10.10.5. Key Strategies and Developments
- 10.11. Phibro Animal Health
- 10.11.1. Company Overview
- 10.11.2. Financial Highlights
- 10.11.3. Product Portfolio
- 10.11.4. SWOT Analysis
- 10.11.5. Key Strategies and Developments
- 10.12. Other Key Players
- 10.12.1. Company Overview
- 10.12.2. Financial Highlights
- 10.12.3. Product Portfolio
- 10.12.4. SWOT Analysis
- 10.12.5. Key Strategies and Developments
- 11. Assumptions and Acronyms
- 12. Research Methodology
- 13. Contact
- List of Figures
- Figure 1: Global Swine Vaccines Revenue (US$ Mn) Market Share by Product in 2022
- Figure 2: Global Swine Vaccines Market Attractiveness Analysis by Product, 2016-2032
- Figure 3: Global Swine Vaccines Revenue (US$ Mn) Market Share by Typein 2022
- Figure 4: Global Swine Vaccines Market Attractiveness Analysis by Type, 2016-2032
- Figure 5: Global Swine Vaccines Revenue (US$ Mn) Market Share by Region in 2022
- Figure 6: Global Swine Vaccines Market Attractiveness Analysis by Region, 2016-2032
- Figure 7: Global Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Figure 8: Global Swine Vaccines Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Figure 9: Global Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Figure 10: Global Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 11: Global Swine Vaccines Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Figure 12: Global Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Figure 13: Global Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 14: Global Swine Vaccines Market Share Comparison by Region (2016-2032)
- Figure 15: Global Swine Vaccines Market Share Comparison by Product (2016-2032)
- Figure 16: Global Swine Vaccines Market Share Comparison by Type (2016-2032)
- Figure 17: North America Swine Vaccines Revenue (US$ Mn) Market Share by Productin 2022
- Figure 18: North America Swine Vaccines Market Attractiveness Analysis by Product, 2016-2032
- Figure 19: North America Swine Vaccines Revenue (US$ Mn) Market Share by Typein 2022
- Figure 20: North America Swine Vaccines Market Attractiveness Analysis by Type, 2016-2032
- Figure 21: North America Swine Vaccines Revenue (US$ Mn) Market Share by Country in 2022
- Figure 22: North America Swine Vaccines Market Attractiveness Analysis by Country, 2016-2032
- Figure 23: North America Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Figure 24: North America Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 25: North America Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Figure 26: North America Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 27: North America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 28: North America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Figure 29: North America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 30: North America Swine Vaccines Market Share Comparison by Country (2016-2032)
- Figure 31: North America Swine Vaccines Market Share Comparison by Product (2016-2032)
- Figure 32: North America Swine Vaccines Market Share Comparison by Type (2016-2032)
- Figure 33: Europe Swine Vaccines Revenue (US$ Mn) Market Share by Productin 2022
- Figure 34: Europe Swine Vaccines Market Attractiveness Analysis by Product, 2016-2032
- Figure 35: Europe Swine Vaccines Revenue (US$ Mn) Market Share by Typein 2022
- Figure 36: Europe Swine Vaccines Market Attractiveness Analysis by Type, 2016-2032
- Figure 37: Europe Swine Vaccines Revenue (US$ Mn) Market Share by Country in 2022
- Figure 38: Europe Swine Vaccines Market Attractiveness Analysis by Country, 2016-2032
- Figure 39: Europe Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Figure 40: Europe Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 41: Europe Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Figure 42: Europe Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 43: Europe Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 44: Europe Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Figure 45: Europe Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 46: Europe Swine Vaccines Market Share Comparison by Country (2016-2032)
- Figure 47: Europe Swine Vaccines Market Share Comparison by Product (2016-2032)
- Figure 48: Europe Swine Vaccines Market Share Comparison by Type (2016-2032)
- Figure 49: Asia-Pacific Swine Vaccines Revenue (US$ Mn) Market Share by Productin 2022
- Figure 50: Asia-Pacific Swine Vaccines Market Attractiveness Analysis by Product, 2016-2032
- Figure 51: Asia-Pacific Swine Vaccines Revenue (US$ Mn) Market Share by Typein 2022
- Figure 52: Asia-Pacific Swine Vaccines Market Attractiveness Analysis by Type, 2016-2032
- Figure 53: Asia-Pacific Swine Vaccines Revenue (US$ Mn) Market Share by Country in 2022
- Figure 54: Asia-Pacific Swine Vaccines Market Attractiveness Analysis by Country, 2016-2032
- Figure 55: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Figure 56: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 57: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Figure 58: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 59: Asia-Pacific Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 60: Asia-Pacific Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Figure 61: Asia-Pacific Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 62: Asia-Pacific Swine Vaccines Market Share Comparison by Country (2016-2032)
- Figure 63: Asia-Pacific Swine Vaccines Market Share Comparison by Product (2016-2032)
- Figure 64: Asia-Pacific Swine Vaccines Market Share Comparison by Type (2016-2032)
- Figure 65: South America Swine Vaccines Revenue (US$ Mn) Market Share by Productin 2022
- Figure 66: South America Swine Vaccines Market Attractiveness Analysis by Product, 2016-2032
- Figure 67: South America Swine Vaccines Revenue (US$ Mn) Market Share by Typein 2022
- Figure 68: South America Swine Vaccines Market Attractiveness Analysis by Type, 2016-2032
- Figure 69: South America Swine Vaccines Revenue (US$ Mn) Market Share by Country in 2022
- Figure 70: South America Swine Vaccines Market Attractiveness Analysis by Country, 2016-2032
- Figure 71: South America Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Figure 72: South America Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 73: South America Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Figure 74: South America Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 75: South America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 76: South America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Figure 77: South America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 78: South America Swine Vaccines Market Share Comparison by Country (2016-2032)
- Figure 79: South America Swine Vaccines Market Share Comparison by Product (2016-2032)
- Figure 80: South America Swine Vaccines Market Share Comparison by Type (2016-2032)
- Figure 81: Middle East and Africa Swine Vaccines Revenue (US$ Mn) Market Share by Productin 2022
- Figure 82: Middle East and Africa Swine Vaccines Market Attractiveness Analysis by Product, 2016-2032
- Figure 83: Middle East and Africa Swine Vaccines Revenue (US$ Mn) Market Share by Typein 2022
- Figure 84: Middle East and Africa Swine Vaccines Market Attractiveness Analysis by Type, 2016-2032
- Figure 85: Middle East and Africa Swine Vaccines Revenue (US$ Mn) Market Share by Country in 2022
- Figure 86: Middle East and Africa Swine Vaccines Market Attractiveness Analysis by Country, 2016-2032
- Figure 87: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Figure 88: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 89: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Figure 90: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 91: Middle East and Africa Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 92: Middle East and Africa Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Figure 93: Middle East and Africa Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 94: Middle East and Africa Swine Vaccines Market Share Comparison by Country (2016-2032)
- Figure 95: Middle East and Africa Swine Vaccines Market Share Comparison by Product (2016-2032)
- Figure 96: Middle East and Africa Swine Vaccines Market Share Comparison by Type (2016-2032)
- List of Tables
- Table 1: Global Swine Vaccines Market Comparison by Product (2016-2032)
- Table 2: Global Swine Vaccines Market Comparison by Type (2016-2032)
- Table 3: Global Swine Vaccines Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 4: Global Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Table 5: Global Swine Vaccines Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 6: Global Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Table 7: Global Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 8: Global Swine Vaccines Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Table 9: Global Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Table 10: Global Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 11: Global Swine Vaccines Market Share Comparison by Region (2016-2032)
- Table 12: Global Swine Vaccines Market Share Comparison by Product (2016-2032)
- Table 13: Global Swine Vaccines Market Share Comparison by Type (2016-2032)
- Table 14: North America Swine Vaccines Market Comparison by Type (2016-2032)
- Table 15: North America Swine Vaccines Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 16: North America Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Table 17: North America Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 18: North America Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Table 19: North America Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 20: North America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 21: North America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Table 22: North America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 23: North America Swine Vaccines Market Share Comparison by Country (2016-2032)
- Table 24: North America Swine Vaccines Market Share Comparison by Product (2016-2032)
- Table 25: North America Swine Vaccines Market Share Comparison by Type (2016-2032)
- Table 26: Europe Swine Vaccines Market Comparison by Product (2016-2032)
- Table 27: Europe Swine Vaccines Market Comparison by Type (2016-2032)
- Table 28: Europe Swine Vaccines Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 29: Europe Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Table 30: Europe Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 31: Europe Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Table 32: Europe Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 33: Europe Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 34: Europe Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Table 35: Europe Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 36: Europe Swine Vaccines Market Share Comparison by Country (2016-2032)
- Table 37: Europe Swine Vaccines Market Share Comparison by Product (2016-2032)
- Table 38: Europe Swine Vaccines Market Share Comparison by Type (2016-2032)
- Table 39: Asia-Pacific Swine Vaccines Market Comparison by Product (2016-2032)
- Table 40: Asia-Pacific Swine Vaccines Market Comparison by Type (2016-2032)
- Table 41: Asia-Pacific Swine Vaccines Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 42: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Table 43: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 44: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Table 45: Asia-Pacific Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 46: Asia-Pacific Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 47: Asia-Pacific Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Table 48: Asia-Pacific Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 49: Asia-Pacific Swine Vaccines Market Share Comparison by Country (2016-2032)
- Table 50: Asia-Pacific Swine Vaccines Market Share Comparison by Product (2016-2032)
- Table 51: Asia-Pacific Swine Vaccines Market Share Comparison by Type (2016-2032)
- Table 52: South America Swine Vaccines Market Comparison by Product (2016-2032)
- Table 53: South America Swine Vaccines Market Comparison by Type (2016-2032)
- Table 54: South America Swine Vaccines Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 55: South America Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Table 56: South America Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 57: South America Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Table 58: South America Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 59: South America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 60: South America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Table 61: South America Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 62: South America Swine Vaccines Market Share Comparison by Country (2016-2032)
- Table 63: South America Swine Vaccines Market Share Comparison by Product (2016-2032)
- Table 64: South America Swine Vaccines Market Share Comparison by Type (2016-2032)
- Table 65: Middle East and Africa Swine Vaccines Market Comparison by Product (2016-2032)
- Table 66: Middle East and Africa Swine Vaccines Market Comparison by Type (2016-2032)
- Table 67: Middle East and Africa Swine Vaccines Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 68: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) (2016-2032)
- Table 69: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 70: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) Comparison by Product (2016-2032)
- Table 71: Middle East and Africa Swine Vaccines Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 72: Middle East and Africa Swine Vaccines Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 73: Middle East and Africa Swine Vaccines Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
- Table 74: Middle East and Africa Swine Vaccines Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 75: Middle East and Africa Swine Vaccines Market Share Comparison by Country (2016-2032)
- Table 76: Middle East and Africa Swine Vaccines Market Share Comparison by Product (2016-2032)
- Table 77: Middle East and Africa Swine Vaccines Market Share Comparison by Type (2016-2032)
- 1. Executive Summary
- Merck & Co., Inc.
- Zoetis
- Boehringer Ingelheim GmbH
- Elanco
- Indian Immunologicals Ltd.
- BiogénesisBagó
- Phibro Animal Health
- KM Biologics
- HIPRA
- Virbac
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible Single User $4,599 $3,499 USD / per unit save 24% | Multi User $5,999 $4,299 USD / per unit save 28% | Corporate User $7,299 $4,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,499) | Buy Now ($ 4,299) | Buy Now ($ 4,999) |